BIOCHEMFUSION ApS: Financial statements 2025
CVR: 32057446
Source: annual report 2025, Danish Business Authority
01/01/2025 – 31/12/2025
BIOCHEMFUSION ApS (CVR 32057446) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK 1,156,041 and a net result of DKK 194,096 compared with DKK -4,593 the year before. That is an increase of 69.3% compared with the year before. Equity in the 2025 report amounted to DKK 475,167. The solvency ratio was 56.6%.
- Gross Profit
- DKK 1,156,041
- Profit/Loss
- DKK 194,096
- Equity
- DKK 475,167
- Total Assets
- DKK 839,742
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2025 | - | 1.2 mio. | 194 t. | 475 t. | - |
| 2024 | - | 683 t. | -5 t. | 281 t. | - |
| 2023 | - | 824 t. | 83 t. | 361 t. | - |
| 2022 | - | 713 t. | -13 t. | 277 t. | - |
| 2021 | - | 946 t. | 190 t. | 440 t. | - |
Official annual report
How creditworthy is BIOCHEMFUSION ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2025
BIOCHEMFUSION ApS has published its annual report for 2024. Gross profit came to DKK 682,776, and the net result was DKK -4,593.
About BIOCHEMFUSION ApS
BIOCHEMFUSION ApS is a Danish company of the type Anpartsselskab based in Ølsted, founded in 2009. The company is registered under the industry Anden udgivelse af software. The management consists of Jan Holst Jensen. The company is owned by BIOCHEMFUSION HOLDING ApS. In 2025, the company reported a gross profit of DKK 1,156,041 and a net result of DKK 194,096 compared with DKK -4,593 the year before. Equity in the 2025 report amounted to DKK 475,167.